Regulatory Framework · 2.5 Mental Health and Vulnerable Groups

No verifiable compliance.

Mexico has a strong legal basis for the general recognition and inclusion of Indigenous peoples and communities. Article 2 of the Constitution recognizes self-determination, autonomy, consultation, normative systems, languages, cultural specificities, traditional medicine, and traditional midwifery. The General Health Law incorporates elements of intercultural health, Indigenous traditional medicine, and traditional midwifery. The INPI Law provides federal institutional capacity to coordinate public policies with Indigenous and Afro-Mexican peoples and communities, and the General Law on Indigenous Linguistic Rights reinforces linguistic access to public services.

This framework is relevant, but it is cross-cutting and does not by itself constitute a specific framework for Indigenous inclusion in drug policy. The reviewed evidence does not identify sector-specific provisions, programmes, or mechanisms that verifiably connect these general rights with prevention, harm reduction, addiction treatment, cannabis, mental health, or substance-related criminal justice.

The sources establish collective rights, consultation, and interculturality in general terms, but they do not demonstrate that drug-policy programmes have been co-designed, consulted, implemented, evaluated, or governed directly with Indigenous communities.

ILO Convention No. 169 serves as an international benchmark for consultation and participation, but it does not replace Mexican implementation evidence. It also does not activate Factor X because it does not demonstrate indicator-specific international cooperation linked to domestic drug-policy implementation.

The territorial review confirms the evidentiary limit. Mexico City, Puebla, Oaxaca, and Chiapas remain sentinel gaps; Guerrero, Yucatán, Chihuahua, and Veracruz remain complementary gaps. These territories are relevant due to Indigenous presence, linguistic diversity, community systems, or territorial vulnerability, but the table does not contain verifiable evidence of direct Indigenous community participation in the design, execution, evaluation, or governance of substance-related policies.

The Manual’s general rule allowing yellow where a relevant legal or policy framework exists without proven implementation is insufficient in this case because the identified framework is general and cross-cutting rather than specific to the sectoral object being assessed.

Consequently, Mexico demonstrates general Indigenous inclusion at the constitutional, health, institutional, and linguistic levels, but not specific, systematic, and evaluated Indigenous inclusion in drug policy. Under RC2 criteria, no verifiable compliance is the correct classification. Factor X does not apply.